Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Research question</h3><p>Whether melatonin can provide non-invasive ovarian protection against damage caused by cis-diamminedichloroplatinum (cisplatin) and preserve fertility for female cancer patients? And what is the possible mechanism if it is the case?</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Design</h3><p>Athymic BALB/c-nu nude tumor-bearing female mice were employed to exclude the antagonistic effect towards cisplatin-based anticancer therapy and promoting cancer effect of melatonin. Sexually mature and newborn C57BL/6 female mice were used to evaluate the potential effects of melatonin towards ovarian follicle pool, pregnant rate and litter number for cisplatin-treated mice and their ovaries were used to perform Immunohistochemistry, TUNEL and gene array to explore the underlying mechanism. We also isolated granulosa cells to confirm the potential protective mechanism of melatonin</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Not only could melatonin enhance the anti-cancer effect of cisplatin in tumor-bearing nude mice, but also it could reduce ovarian toxicity and preserved long-term fertility in cisplatin treated C57BL/6 female mice. Mechanistically, when co-administrated, melatonin could reduce DNA damage and relieve toxicity of lipid peroxidation in ovary caused by cisplatin. Specially, melatonin could largely removelipid peroxidation in granulosa cells and thus prevent ovarian follicles from being depleted.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Melatonin has potential to be used as a chemotherapeutic adjuvant to improve anti-cancer outcome and to preserve ovarian function for cisplatin chemotherapy simultaneously. Notably, its DNA protection and antioxidant effects on follicles may benefit female cancer survivors and prevent premature ovarian failure (POF) as well as fertility loss caused by chemotherapy.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">KEY MESSAGE</h3><p>Ovarian reserve preservation and its mechanism of melatonin against cisplatin-induced ovarian damage have been explored. The better control of tumor and better ovarian reserve and fertility of female mice when melatonin was co-administrated with cisplatin indicates melatonin may be a promising fertoprotective agent for cisplatin-treated female cancer patients.</p>

Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice

Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats

Melatonin Protects Against Epirubicin-induced Ovarian Damage.

THE PROTECTIVE EFFECT OF MELATONIN ON AUDITORY CORTEX TOXICITY INDUCED BY CIS-PLATINUM

Melatonin alleviates cisplatin-induced mice spermatogenesis defects

Melatonin attenuates cisplatin-induced acute kidney injury in mice: Involvement of PPARα and fatty acid oxidation

Melatonin regulates cancer migration and stemness and enhances the anti-tumour effect of cisplatin

Activation of MT1/MT2 to Protect Testes and Leydig Cells against Cisplatin-Induced Oxidative Stress through the SIRT1/Nrf2 Signaling Pathway

Melatonin Mitigates Cisplatin-Induced Submandibular Gland Damage by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Fibrosis

Melatonin in the prevention of cisplatin-induced acute nephrotoxicity: a randomized, controlled clinical trial

Melatonin Prevents Cyclophosphamide-Induced Primordial Follicle Loss by Inhibiting Ovarian Granulosa Cell Apoptosis and Maintaining AMH Expression

Protective and Sensitive Effects of Melatonin Combined with Adriamycin on ER+ (estrogen Receptor) Breast Cancer.

Protective Effects Of Melatonin Agonist On Radiotherapy-Induced Ovarian Damage In Rats

Melatonin Protects Against Cyclophosphamide-induced Premature Ovarian Failure in Rats

Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK/Parkin/mitophagy axis

Melatonin protects ovarian function in whole cryopreserved rat ovarian transplantation via the MT1/Nrf2/ARE pathway

Melatonin improves mouse oocyte quality from 2-ethylhexyl diphenyl phosphate-induced toxicity by enhancing mitochondrial function

Melatonin activates Nrf2/HO-1 signalling pathway to antagonizes oxidative stress-induced injury via melatonin receptor 1 (MT1) in cryopreserved mice ovarian tissue

Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice

Melatonin and Ovarian Tissue Transplantation: Current Frontiers in Research